Christopher G. Hayes
2023
In 2023, Christopher G. Hayes earned a total compensation of $2.6M as Chief Legal Officer at Verrica Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $169,600 |
|---|---|
| Option Awards | $817,925 |
| Salary | $424,000 |
| Stock Awards | $1,137,000 |
| Other | $13,779 |
| Total | $2,561,674 |
Hayes received $1.1M in stock awards, accounting for 44% of the total pay in 2023.
Hayes also received $169.6K in non-equity incentive plan, $817.9K in option awards, $424K in salary and $13.8K in other compensation.
Rankings
In 2023, Christopher G. Hayes' compensation ranked 379th out of 2,978 executives tracked by ExecPay. In other words, Hayes earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 379 out of 2,978 | 87th |
Division Manufacturing | 215 out of 1,637 | 87th |
Major group Chemicals And Allied Products | 150 out of 906 | 83rd |
Industry group Drugs | 147 out of 869 | 83rd |
Industry Pharmaceutical Preparations | 89 out of 627 | 86th |
Source: SEC filing on April 19, 2024.
Hayes' colleagues
We found two more compensation records of executives who worked with Christopher G. Hayes at Verrica Pharmaceuticals in 2023.